Description
Recombinant monoclonal antibody to MOG. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 8.18-C5.
Target
MOG
Target Alias Names
Myelin-oligodendrocyte glycoprotein, 8.18C5, 8-18C5
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression